These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3352795

  • 41. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens.
    Cheng MF, Chatterjee S, Berger NA.
    Oncol Res; 1994; 6(6):269-79. PubMed ID: 7865902
    [Abstract] [Full Text] [Related]

  • 42. Cytotoxicity of cisplatin and cisdiammine-1,1-cyclobutane dicarboxylate in MGH-U1 cells grown as monolayers, spheroids, and xenografts.
    Erlichman C, Vidgen D, Wu A.
    J Natl Cancer Inst; 1985 Sep; 75(3):499-505. PubMed ID: 3897683
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
    Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N.
    Cancer Lett; 2005 Jun 16; 224(1):53-65. PubMed ID: 15911101
    [Abstract] [Full Text] [Related]

  • 46. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y, Deen DF, Oredsson SM, Marton LJ.
    Cancer Res; 1984 Feb 16; 44(2):577-81. PubMed ID: 6420048
    [Abstract] [Full Text] [Related]

  • 47. The heterogenous cytotoxic response of colon cancer cells is unrelated to phenotypic differentiation characteristics.
    Drewinko B, Yang LY.
    Anticancer Res; 1988 Feb 16; 8(1):161-4. PubMed ID: 3128957
    [Abstract] [Full Text] [Related]

  • 48. Distribution and activity of antineoplastic drugs in a tumor model.
    Durand RE.
    J Natl Cancer Inst; 1989 Jan 18; 81(2):146-52. PubMed ID: 2909755
    [Abstract] [Full Text] [Related]

  • 49. Interactions of radiation and adriamycin, bleomycin, mitomycin C or cis-diamminedichloroplatinum II in intestinal crypt cells.
    von der Maase H.
    Br J Cancer; 1984 Jun 18; 49(6):779-86. PubMed ID: 6203548
    [Abstract] [Full Text] [Related]

  • 50. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour.
    von der Maase H.
    Radiother Oncol; 1986 Sep 18; 7(1):47-68. PubMed ID: 2430317
    [Abstract] [Full Text] [Related]

  • 51. Elimination of hypoxic protection by 5-thio-D-glucose in multicell spheroids.
    Song CW, Clement JJ, Levitt SH.
    Cancer Res; 1978 Dec 18; 38(12):4499-503. PubMed ID: 719634
    [Abstract] [Full Text] [Related]

  • 52. [Growth of tumour-cell colonies from human solid tumours (author's transl)].
    Schlag P, Wolfrum J, Vergani G, Schreml W, Herfarth C.
    Dtsch Med Wochenschr; 1982 Aug 06; 107(31-32):1173-7. PubMed ID: 6179731
    [Abstract] [Full Text] [Related]

  • 53. Heterogeneous effects of interferon on antitumor agents' cytotoxicities to human colon carcinoma cell lines.
    Trujillo JM, Yang LY, Gercovich G, Su YZ.
    Anticancer Res; 1991 Aug 06; 11(1):439-44. PubMed ID: 1902077
    [Abstract] [Full Text] [Related]

  • 54. Adriamycin: a possible indirect radiosensitizer of hypoxic tumor cells.
    Durand RE.
    Radiology; 1976 Apr 06; 119(1):217-22. PubMed ID: 1257446
    [Abstract] [Full Text] [Related]

  • 55. Surgical adjuvant therapy in colon carcinoma: a human tumor spheroid model for evaluating radiation sensitizing agents.
    Barone RM, Calabro-Jones P, Thomas TN, Sharp TR, Byfield JE.
    Cancer; 1981 May 15; 47(10):2349-57. PubMed ID: 7272891
    [Abstract] [Full Text] [Related]

  • 56. Sequencing radiation and adriamycin exposures in spheroids to maximize therapeutic gain.
    Durand RE, Vanderbyl SL.
    Int J Radiat Oncol Biol Phys; 1989 Aug 15; 17(2):345-50. PubMed ID: 2753758
    [Abstract] [Full Text] [Related]

  • 57. Cytotoxicities of mitomycin C and x rays to aerobic and hypoxic cells in vitro.
    Rockwell S.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(6):1035-9. PubMed ID: 6809713
    [Abstract] [Full Text] [Related]

  • 58. Synergism of cisplatin and mitomycin C in sensitive and resistant cell subpopulations of a tumor model.
    Durand RE.
    Int J Cancer; 1989 Nov 15; 44(5):911-7. PubMed ID: 2511158
    [Abstract] [Full Text] [Related]

  • 59. HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroids.
    Bichay TJ, Adams EG, Inch WR, Adams WJ, Brewer JE, Bhuyan BK.
    Sel Cancer Ther; 1990 Nov 15; 6(4):153-66. PubMed ID: 2151298
    [Abstract] [Full Text] [Related]

  • 60. Potentiation of CCNU toxicity by AF-2 in V79 spheroids: implications for mechanisms of chemosensitization.
    Durand RE, Olive PL.
    Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1375-8. PubMed ID: 3759558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.